ConductScience.org, home

Paper33330100

Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease.

Suresh D and 2 others. Front Oncol, 2020. Cited by 141 papers, by iCite.

Cite this record

ConductScience Library. Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease. Papers, record 33330100. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33330100

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease.
PubMed
Journal
Front Oncol
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
141
iCite
Relative citation ratio, by iCite
7.05
iCite
Revised in PubMed
2020-12-18
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Suresh DDiwakar
2Srinivas ANAkshatha N
3Kumar DPDivya P

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References110

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132486341Lipid Metabolism in Development and Progression of Hepatocellular Carcinoma.Cancers (Basel)2020https://conductscience.org/library/papers/32486341PubMed
215565570Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.Hepatology2004https://conductscience.org/library/papers/15565570PubMed
330658729Hepatocellular carcinoma in the setting of alcohol-related liver disease.J Hepatol2019https://conductscience.org/library/papers/30658729PubMed
430119271Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management.Biomed Pharmacother2018https://conductscience.org/library/papers/30119271PubMed
58921985Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis.Mutat Res1996https://conductscience.org/library/papers/8921985PubMed
628983565The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015.JAMA Oncol2017https://conductscience.org/library/papers/28983565PubMed
727986466Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies.Trends Endocrinol Metab2017https://conductscience.org/library/papers/27986466PubMed
829359013Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection.World J Hepatol2017https://conductscience.org/library/papers/29359013PubMed
922467277Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease.Hepatology2012https://conductscience.org/library/papers/22467277PubMed
1024978903TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.Nat Commun2014https://conductscience.org/library/papers/24978903PubMed
1116447287Nonalcoholic fatty liver disease: from steatosis to cirrhosis.Hepatology2006https://conductscience.org/library/papers/16447287PubMed
1231728429Hepatocellular carcinoma in alcoholic and non-alcoholic fatty liver disease-one of a kind or two different enemies?Transl Gastroenterol Hepatol2019https://conductscience.org/library/papers/31728429PubMed
1331060311Role of Gut Microbiota in Hepatocarcinogenesis.Microorganisms2019https://conductscience.org/library/papers/31060311PubMed
1416527702The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence.Clin Gastroenterol Hepatol2006https://conductscience.org/library/papers/16527702PubMed
1531024205Hepatocellular Carcinoma: Etiology and Current and Future Drugs.J Clin Exp Hepatol2019https://conductscience.org/library/papers/31024205PubMed
1612390068Racial and ethnic differences in alcohol-associated aspartate aminotransferase and gamma-glutamyltransferase elevation.Arch Intern Med2002https://conductscience.org/library/papers/12390068PubMed
1712395331Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus.Hepatology2002https://conductscience.org/library/papers/12395331PubMed
1823162602Alpha-1-antitrypsin in pathogenesis of hepatocellular carcinoma.Hepat Mon2012https://conductscience.org/library/papers/23162602PubMed
1930076710MicroRNAs in alcoholic liver disease: Recent advances and future applications.J Cell Physiol2018https://conductscience.org/library/papers/30076710PubMed
2094825074-Aminobiphenyl DNA damage in liver tissue of hepatocellular carcinoma patients and controls.Am J Epidemiol1998https://conductscience.org/library/papers/9482507PubMed

See all 110 referencesDownload CSV of references

Cited by113

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 141 citations.

PMIDTitleJournalYearIn PapersSource
42827771Scoparone protects against acetaminophen-induced acute liver injury: Insights from In vivo experiments and RNA sequencing.Biochem Biophys Rep2026https://conductscience.org/library/papers/42827771PubMed
42591901Palmitoylation-related gene signature for immune subtyping, prognostic stratification, and immunotherapy guidance in hepatocellular carcinoma.Transl Cancer Res2026https://conductscience.org/library/papers/42591901PubMed
42449680The Effect of Statin Therapy on the Overall Survival of Patients with Hepatocellular Carcinoma: A Single-Center Experience.Cancers (Basel)2026https://conductscience.org/library/papers/42449680PubMed
42395637Emerging role of proteomics in advancing diagnosis, prognosis, and treatment of liver cancer.Liver Res2026https://conductscience.org/library/papers/42395637PubMed
42371299Decoding the functional landscape of long non-coding RNAs in hepatocellular carcinoma: molecular mechanisms, clinical implications, and therapeutic prospects.J Egypt Natl Canc Inst2026https://conductscience.org/library/papers/42371299PubMed
42166032Advanced liposomal nanoplatforms for flavonoid delivery: a mechanistic and comparative perspective in hepatocellular carcinoma.Discov Oncol2026https://conductscience.org/library/papers/42166032PubMed
42046763Trans-Arterial Chemoembolization Combined with Microwave Ablation versus Microwave Ablation Alone for 3-5 cm Hepatocellular Carcinoma: A Multicenter Retrospective Study.J Hepatocell Carcinoma2026https://conductscience.org/library/papers/42046763PubMed
41937404Meta-Analysis of Genetic Variants Associated With HBV Infection Susceptibility and Hepatocellular Carcinoma Risk.J Viral Hepat2026https://conductscience.org/library/papers/41937404PubMed
41822854Therapeutic Potential of Silver Nanoparticles in Hepatocellular Carcinoma: From Pathogenesis to Clinical Perspectives.Int J Nanomedicine2026https://conductscience.org/library/papers/41822854PubMed
41810934Mechanisms of Action and Biomarker Potential of ncRNAs in Hepatocellular Carcinoma and Liver Fibrosis: A Review.Anal Cell Pathol (Amst)2026https://conductscience.org/library/papers/41810934PubMed
41808116ICMT deficiency ameliorates weight loss and mortality, but not tumor formation in a mouse model of liver cancer.Cell Commun Signal2026https://conductscience.org/library/papers/41808116PubMed
41647281Immune checkpoint inhibition (ICI) in current systemic therapies for hepatocellular carcinoma (HCC).ESMO Gastrointest Oncol2023https://conductscience.org/library/papers/41647281PubMed
41639358Temporal trends and regional variations in hepatocellular carcinoma etiology: a multinational study across Asia.Hepatol Int2026https://conductscience.org/library/papers/41639358PubMed
41602129Metabolites involvement in the growth and spread of liver cancer.Liver Res2025https://conductscience.org/library/papers/41602129PubMed
41589205Role of insulin-like growth factor/receptor signaling in hepatocellular carcinoma.Hepatol Forum2026https://conductscience.org/library/papers/41589205PubMed
41527027Hepatic loss of AATF attenuates MASH by suppressing AKT-mTORC1 signaling and reprogramming lipid metabolism.Mol Med2026https://conductscience.org/library/papers/41527027PubMed
41526557Pathobiological Dictionary Defining Pathomics and Texture Features: Addressing Understandable AI Issues in Personalized Liver Cancer; Dictionary Version LCP1.0.J Imaging Inform Med2026https://conductscience.org/library/papers/41526557PubMed
41465202Putative Role of Fatty Acid Metabolic Therapy Using Ketogenic Diet and HIF-1α Inhibition in Hepatocellular Carcinoma: Evidence from an In Vitro Study.Int J Mol Sci2025https://conductscience.org/library/papers/41465202PubMed
41462859Atezolizumab Plus Bevacizumab Combination Therapy in Unresectable Hepatocellular Carcinoma: An Institutional Experience.Biomedicines2025https://conductscience.org/library/papers/41462859PubMed
41345959YAP-induced MAML1 cooperates with STAT3 to drive hepatocellular carcinoma progression.Exp Hematol Oncol2025https://conductscience.org/library/papers/41345959PubMed

See all 113 cited byDownload CSV of cited by

Genes20

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ADIPOQ9370PubTator's text mininghttps://conductscience.org/library/genes/9370NCBI Gene
AKR1A110327PubTator's text mininghttps://conductscience.org/library/genes/10327NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
CYP2E11571PubTator's text mininghttps://conductscience.org/library/genes/1571NCBI Gene
IGF13479PubTator's text mininghttps://conductscience.org/library/genes/3479NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
LEP3952PubTator's text mininghttps://conductscience.org/library/genes/3952NCBI Gene
MAPK85599PubTator's text mininghttps://conductscience.org/library/genes/5599NCBI Gene
NRF14899PubTator's text mininghttps://conductscience.org/library/genes/4899NCBI Gene
PNPLA380339PubTator's text mininghttps://conductscience.org/library/genes/80339NCBI Gene
PPARA5465PubTator's text mininghttps://conductscience.org/library/genes/5465NCBI Gene
RETN56729PubTator's text mininghttps://conductscience.org/library/genes/56729NCBI Gene
STAT36774PubTator's text mininghttps://conductscience.org/library/genes/6774NCBI Gene
TAOK351347PubTator's text mininghttps://conductscience.org/library/genes/51347NCBI Gene
TM6SF253345PubTator's text mininghttps://conductscience.org/library/genes/53345NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33330100

GET https://conductscience.org/api/papers/v1/33330100/references?page=2